調査レポート | • レポートコード：QYR2104Z4436 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、パーキンソン病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シネメットCR、トラスタル、マドパー、COMT阻害剤、その他）、用途別市場規模（40歳以下、40〜65歳、65歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・パーキンソン病治療薬の市場動向 ・企業の競争状況、市場シェア ・パーキンソン病治療薬の種類別市場規模（シネメットCR、トラスタル、マドパー、COMT阻害剤、その他） ・パーキンソン病治療薬の用途別市場規模（40歳以下、40〜65歳、65歳以上） ・パーキンソン病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・パーキンソン病治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・パーキンソン病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パーキンソン病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・パーキンソン病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Akorn、GSK、Novartis、Boehringer Ingelheim、Teva Pharmaceutical、Abbvie、Kyowa Hakko Kirin Pharma、Astellas Pharma、Desitin Arzneimittel、Endo Pharmaceuticals、F.Hoffmann-La Roche、H.Lundbeck、Valeant、Apokyn、Orion、Stada Arzneimittel、US WorldMeds、Bausch Health） ・結論 |
Market Analysis and Insights: Global Parkinson Disease Drug Market
The global Parkinson Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson Disease Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson Disease Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson Disease Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson Disease Drug market.
Global Parkinson Disease Drug Scope and Market Size
Parkinson Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Novartis
Boehringer Ingelheim
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson Disease Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson Disease Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson Disease Drug Market Perspective (2016-2027)
2.2 Parkinson Disease Drug Growth Trends by Regions
2.2.1 Parkinson Disease Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson Disease Drug Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson Disease Drug Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson Disease Drug Industry Dynamic
2.3.1 Parkinson Disease Drug Market Trends
2.3.2 Parkinson Disease Drug Market Drivers
2.3.3 Parkinson Disease Drug Market Challenges
2.3.4 Parkinson Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson Disease Drug Players by Revenue
3.1.1 Global Top Parkinson Disease Drug Players by Revenue (2016-2021)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson Disease Drug Revenue
3.4 Global Parkinson Disease Drug Market Concentration Ratio
3.4.1 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson Disease Drug Revenue in 2020
3.5 Parkinson Disease Drug Key Players Head office and Area Served
3.6 Key Players Parkinson Disease Drug Product Solution and Service
3.7 Date of Enter into Parkinson Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson Disease Drug Breakdown Data by Type
4.1 Global Parkinson Disease Drug Historic Market Size by Type (2016-2021)
4.2 Global Parkinson Disease Drug Forecasted Market Size by Type (2022-2027)
5 Parkinson Disease Drug Breakdown Data by Application
5.1 Global Parkinson Disease Drug Historic Market Size by Application (2016-2021)
5.2 Global Parkinson Disease Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Parkinson Disease Drug Market Size (2016-2027)
6.2 North America Parkinson Disease Drug Market Size by Type
6.2.1 North America Parkinson Disease Drug Market Size by Type (2016-2021)
6.2.2 North America Parkinson Disease Drug Market Size by Type (2022-2027)
6.2.3 North America Parkinson Disease Drug Market Size by Type (2016-2027)
6.3 North America Parkinson Disease Drug Market Size by Application
6.3.1 North America Parkinson Disease Drug Market Size by Application (2016-2021)
6.3.2 North America Parkinson Disease Drug Market Size by Application (2022-2027)
6.3.3 North America Parkinson Disease Drug Market Size by Application (2016-2027)
6.4 North America Parkinson Disease Drug Market Size by Country
6.4.1 North America Parkinson Disease Drug Market Size by Country (2016-2021)
6.4.2 North America Parkinson Disease Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Parkinson Disease Drug Market Size (2016-2027)
7.2 Europe Parkinson Disease Drug Market Size by Type
7.2.1 Europe Parkinson Disease Drug Market Size by Type (2016-2021)
7.2.2 Europe Parkinson Disease Drug Market Size by Type (2022-2027)
7.2.3 Europe Parkinson Disease Drug Market Size by Type (2016-2027)
7.3 Europe Parkinson Disease Drug Market Size by Application
7.3.1 Europe Parkinson Disease Drug Market Size by Application (2016-2021)
7.3.2 Europe Parkinson Disease Drug Market Size by Application (2022-2027)
7.3.3 Europe Parkinson Disease Drug Market Size by Application (2016-2027)
7.4 Europe Parkinson Disease Drug Market Size by Country
7.4.1 Europe Parkinson Disease Drug Market Size by Country (2016-2021)
7.4.2 Europe Parkinson Disease Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Parkinson Disease Drug Market Size (2016-2027)
8.2 Asia-Pacific Parkinson Disease Drug Market Size by Type
8.2.1 Asia-Pacific Parkinson Disease Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson Disease Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson Disease Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson Disease Drug Market Size by Application
8.3.1 Asia-Pacific Parkinson Disease Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson Disease Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson Disease Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson Disease Drug Market Size by Region
8.4.1 Asia-Pacific Parkinson Disease Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson Disease Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson Disease Drug Market Size (2016-2027)
9.2 Latin America Parkinson Disease Drug Market Size by Type
9.2.1 Latin America Parkinson Disease Drug Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson Disease Drug Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson Disease Drug Market Size by Type (2016-2027)
9.3 Latin America Parkinson Disease Drug Market Size by Application
9.3.1 Latin America Parkinson Disease Drug Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson Disease Drug Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson Disease Drug Market Size by Application (2016-2027)
9.4 Latin America Parkinson Disease Drug Market Size by Country
9.4.1 Latin America Parkinson Disease Drug Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson Disease Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson Disease Drug Market Size (2016-2027)
10.2 Middle East & Africa Parkinson Disease Drug Market Size by Type
10.2.1 Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson Disease Drug Market Size by Application
10.3.1 Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson Disease Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson Disease Drug Market Size by Country
10.4.1 Middle East & Africa Parkinson Disease Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson Disease Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson Disease Drug Introduction
11.1.4 Merck Revenue in Parkinson Disease Drug Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson Disease Drug Introduction
11.2.4 Akorn Revenue in Parkinson Disease Drug Business (2016-2021)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson Disease Drug Introduction
11.3.4 GSK Revenue in Parkinson Disease Drug Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson Disease Drug Introduction
11.4.4 Novartis Revenue in Parkinson Disease Drug Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2016-2021)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson Disease Drug Introduction
11.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2016-2021)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2016-2021)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson Disease Drug Introduction
11.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2016-2021)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2016-2021)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2016-2021)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Details
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson Disease Drug Introduction
11.13.4 H.Lundbeck Revenue in Parkinson Disease Drug Business (2016-2021)
11.13.5 H.Lundbeck Recent Development
11.14 Valeant
11.14.1 Valeant Company Details
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson Disease Drug Introduction
11.14.4 Valeant Revenue in Parkinson Disease Drug Business (2016-2021)
11.14.5 Valeant Recent Development
11.15 Apokyn
11.15.1 Apokyn Company Details
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson Disease Drug Introduction
11.15.4 Apokyn Revenue in Parkinson Disease Drug Business (2016-2021)
11.15.5 Apokyn Recent Development
11.16 Orion
11.16.1 Orion Company Details
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson Disease Drug Introduction
11.16.4 Orion Revenue in Parkinson Disease Drug Business (2016-2021)
11.16.5 Orion Recent Development
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Details
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson Disease Drug Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021)
11.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
11.18.1 US WorldMeds Company Details
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson Disease Drug Introduction
11.18.4 US WorldMeds Revenue in Parkinson Disease Drug Business (2016-2021)
11.18.5 US WorldMeds Recent Development
11.18 Bausch Health
.1 Bausch Health Company Details
.2 Bausch Health Business Overview
.3 Bausch Health Parkinson Disease Drug Introduction
.4 Bausch Health Revenue in Parkinson Disease Drug Business (2016-2021)
.5 Bausch Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson Disease Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Parkinson Disease Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Parkinson Disease Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Parkinson Disease Drug Market Share by Regions (2016-2021)
Table 11. Global Parkinson Disease Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Parkinson Disease Drug Market Share by Regions (2022-2027)
Table 13. Parkinson Disease Drug Market Trends
Table 14. Parkinson Disease Drug Market Drivers
Table 15. Parkinson Disease Drug Market Challenges
Table 16. Parkinson Disease Drug Market Restraints
Table 17. Global Parkinson Disease Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Parkinson Disease Drug Market Share by Players (2016-2021)
Table 19. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson Disease Drug as of 2020)
Table 20. Ranking of Global Top Parkinson Disease Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson Disease Drug Product Solution and Service
Table 24. Date of Enter into Parkinson Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Parkinson Disease Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Parkinson Disease Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Parkinson Disease Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Parkinson Disease Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Parkinson Disease Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Parkinson Disease Drug Product
Table 67. Merck Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Akorn Company Details
Table 70. Akorn Business Overview
Table 71. Akorn Parkinson Disease Drug Product
Table 72. Akorn Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 73. Akorn Recent Development
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Parkinson Disease Drug Product
Table 77. GSK Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 78. GSK Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Parkinson Disease Drug Product
Table 82. Novartis Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Boehringer Ingelheim Company Details
Table 85. Boehringer Ingelheim Business Overview
Table 86. Boehringer Ingelheim Parkinson Disease Drug Product
Table 87. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 88. Boehringer Ingelheim Recent Development
Table 89. Teva Pharmaceutical Company Details
Table 90. Teva Pharmaceutical Business Overview
Table 91. Teva Pharmaceutical Parkinson Disease Drug Product
Table 92. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 93. Teva Pharmaceutical Recent Development
Table 94. Abbvie Company Details
Table 95. Abbvie Business Overview
Table 96. Abbvie Parkinson Disease Drug Product
Table 97. Abbvie Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 98. Abbvie Recent Development
Table 99. Kyowa Hakko Kirin Pharma Company Details
Table 100. Kyowa Hakko Kirin Pharma Business Overview
Table 101. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 102. Kyowa Hakko Kirin Pharma Recent Development
Table 103. Astellas Pharma Company Details
Table 104. Astellas Pharma Business Overview
Table 105. Astellas Pharma Parkinson Disease Drug Product
Table 106. Astellas Pharma Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 107. Astellas Pharma Recent Development
Table 108. Desitin Arzneimittel Company Details
Table 109. Desitin Arzneimittel Business Overview
Table 110. Desitin Arzneimittel Parkinson Disease Drug Product
Table 111. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 112. Desitin Arzneimittel Recent Development
Table 113. Endo Pharmaceuticals Company Details
Table 114. Endo Pharmaceuticals Business Overview
Table 115. Endo Pharmaceuticals Parkinson Disease Drug Product
Table 116. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 117. Endo Pharmaceuticals Recent Development
Table 118. F.Hoffmann-La Roche Company Details
Table 119. F.Hoffmann-La Roche Business Overview
Table 120. F.Hoffmann-La Roche Parkinson Disease Drug Product
Table 121. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 122. F.Hoffmann-La Roche Recent Development
Table 123. H.Lundbeck Company Details
Table 124. H.Lundbeck Business Overview
Table 125. H.Lundbeck Parkinson Disease Drug Product
Table 126. H.Lundbeck Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 127. H.Lundbeck Recent Development
Table 128. Valeant Company Details
Table 129. Valeant Business Overview
Table 130. Valeant Parkinson Disease Drug Product
Table 131. Valeant Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 132. Valeant Recent Development
Table 133. Apokyn Company Details
Table 134. Apokyn Business Overview
Table 135. Apokyn Parkinson Disease Drug Product
Table 136. Apokyn Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 137. Apokyn Recent Development
Table 138. Orion Company Details
Table 139. Orion Business Overview
Table 140. Orion Parkinson Disease Drug Product
Table 141. Orion Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 142. Orion Recent Development
Table 143. Stada Arzneimittel Company Details
Table 144. Stada Arzneimittel Business Overview
Table 145. Stada Arzneimittel Parkinson Disease Drug Product
Table 146. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 147. Stada Arzneimittel Recent Development
Table 148. US WorldMeds Company Details
Table 149. US WorldMeds Business Overview
Table 150. US WorldMeds Parkinson Disease Drug Product
Table 151. US WorldMeds Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 152. US WorldMeds Recent Development
Table 153. Bausch Health Company Details
Table 154. Bausch Health Business Overview
Table 155. Bausch Health Parkinson Disease Drug Product
Table 156. Bausch Health Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)
Table 157. Bausch Health Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson Disease Drug Market Share by Type: 2020 VS 2027
Figure 2. Sinemet-CR Features
Figure 3. Trastal Features
Figure 4. Madopar Features
Figure 5. COMT Inhibitor Features
Figure 6. Other Features
Figure 7. Global Parkinson Disease Drug Market Share by Application: 2020 VS 2027
Figure 8. Under 40 Years Old Case Studies
Figure 9. 40-65 Years Old Case Studies
Figure 10. Above 65 Years Old Case Studies
Figure 11. Parkinson Disease Drug Report Years Considered
Figure 12. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Parkinson Disease Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Parkinson Disease Drug Market Share by Regions: 2020 VS 2027
Figure 15. Global Parkinson Disease Drug Market Share by Regions (2022-2027)
Figure 16. Global Parkinson Disease Drug Market Share by Players in 2020
Figure 17. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson Disease Drug as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2020
Figure 19. Global Parkinson Disease Drug Revenue Market Share by Type (2016-2021)
Figure 20. Global Parkinson Disease Drug Revenue Market Share by Type (2022-2027)
Figure 21. North America Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Parkinson Disease Drug Market Share by Type (2016-2027)
Figure 23. North America Parkinson Disease Drug Market Share by Application (2016-2027)
Figure 24. North America Parkinson Disease Drug Market Share by Country (2016-2027)
Figure 25. United States Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Parkinson Disease Drug Market Share by Type (2016-2027)
Figure 29. Europe Parkinson Disease Drug Market Share by Application (2016-2027)
Figure 30. Europe Parkinson Disease Drug Market Share by Country (2016-2027)
Figure 31. Germany Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Parkinson Disease Drug Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Parkinson Disease Drug Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Parkinson Disease Drug Market Share by Region (2016-2027)
Figure 41. China Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Parkinson Disease Drug Market Share by Type (2016-2027)
Figure 49. Latin America Parkinson Disease Drug Market Share by Application (2016-2027)
Figure 50. Latin America Parkinson Disease Drug Market Share by Country (2016-2027)
Figure 51. Mexico Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Parkinson Disease Drug Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Parkinson Disease Drug Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Parkinson Disease Drug Market Share by Country (2016-2027)
Figure 57. Turkey Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 61. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 66. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 67. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 68. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 69. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 70. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 71. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 72. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 73. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 74. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 75. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 76. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 77. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 78. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界のパーキンソン病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parkinson's Disease Market The global Parkinson's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…- 世界のパーキンソン病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parkinson's Disease Market The global Parkinson's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のパーキンソン病治療薬市場規模・現状・予測（2021年-2027年） Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. Market Analysis and Insights: Global Parkinson’s Disease Therapeutics Market The global Parkinson’s Disease Therapeutics market size is projected to reach US$ 3533.7 million by 2026, from …
- 世界のパーキンソン病治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parkinson's Disease Therapeutics Market The global Parkinson's Disease Therapeutics market size is projected to reach US$ 3533.7 million by 2026, from US$ 2337.8 million in 2019, at a CAGR of 6.0% during 2021-2026. With industry-standard accuracy in analysis and …
- 世界のパーキンソン病治療薬市場 2021：企業別、地域別、種類・用途別 The Parkinson’s Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…